LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
IAMCIK 0001997038

Iambic Therapeutics, Inc.

16 transactions by 11 insiders, from October 14, 2026 to October 14, 2026.

Transactions
1611 insiders
Bought · P
Nonenobody bought on the open market
Sold · S
Nonenobody sold on the open market
Net
+$0net buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Frederick R. ManbyCTO2———
Michael SecoraCFO2———
Neil JosephsonCMO2———
Thomas F. MillerCEO2———
Peter A. OlsonChief2———
R. Jacob VogelsteinDir11/1——
William H. RastetterDir1———
Kurt Von EmsterDir1———
Mary TagliaferriDir1———
Shalini SharpDir1———
Evan Lockwood RachlinDir1———

All transactions

16 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Kurt Von EmsterDirDERIVOct 14A20,300$0.00—?
R. Jacob VogelsteinDirDERIVOct 14APLAN20,300$0.00—?
Mary TagliaferriDirDERIVOct 14A20,300$0.00—?
Shalini SharpDirDERIVOct 14A20,300$0.00—?
William H. RastetterDirDERIVOct 14A40,600$0.00—?
Evan Lockwood RachlinDirDERIVOct 14A20,300$0.00—?
Michael SecoraCFODERIVOct 14A170,300$0.00—?
Michael SecoraCFOOct 14A28,400$0.00—
Peter A. OlsonChiefDERIVOct 14A116,900$0.00—?
Peter A. OlsonChiefOct 14A19,500$0.00—
Neil JosephsonCMODERIVOct 14A185,900$0.00—?
Neil JosephsonCMOOct 14A31,000$0.00—
Frederick R. ManbyCTODERIVOct 14A793,200$0.00—?
Frederick R. ManbyCTOOct 14A132,200$0.00—
Thomas F. MillerCEODERIVOct 14A793,200$0.00—?
Thomas F. MillerCEOOct 14A132,200$0.00—